AAL VARIABLE PRODUCT SERIES FUND INC
NSAR-A, EX-27, 2000-08-28
Previous: AAL VARIABLE PRODUCT SERIES FUND INC, NSAR-A, EX-27, 2000-08-28
Next: ICN PHARMACEUTICALS INC, SC 13D/A, 2000-08-28



<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000927648
<NAME> AAL VARIABLE PRODUCT SERIES FUND, INC.
<SERIES>
   <NUMBER> 4
   <NAME> AAL VARIABLE PRODUCT BALANCED PORTFOLIO
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<INVESTMENTS-AT-COST>                        722602893
<INVESTMENTS-AT-VALUE>                       816748368
<RECEIVABLES>                                  5092853
<ASSETS-OTHER>                                     332
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                               821841553
<PAYABLE-FOR-SECURITIES>                       2000826
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                       592650
<TOTAL-LIABILITIES>                            2593476
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                     698450330
<SHARES-COMMON-STOCK>                         49123796
<SHARES-COMMON-PRIOR>                         46501710
<ACCUMULATED-NII-CURRENT>                       153758
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                       26498514
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                      94145475
<NET-ASSETS>                                 819248077
<DIVIDEND-INCOME>                              2426878
<INTEREST-INCOME>                             12347443
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                 1238076
<NET-INVESTMENT-INCOME>                       13536245
<REALIZED-GAINS-CURRENT>                      17717821
<APPREC-INCREASE-CURRENT>                   (19402826)
<NET-CHANGE-FROM-OPS>                         11851240
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                   (13424191)
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                        3848124
<NUMBER-OF-SHARES-REDEEMED>                  (2044310)
<SHARES-REINVESTED>                             818272
<NET-CHANGE-IN-ASSETS>                        41602453
<ACCUMULATED-NII-PRIOR>                          41704
<ACCUMULATED-GAINS-PRIOR>                      8780693
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                          1238076
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                1391254
<AVERAGE-NET-ASSETS>                         788628522
<PER-SHARE-NAV-BEGIN>                            16.72
<PER-SHARE-NII>                                   0.28
<PER-SHARE-GAIN-APPREC>                         (0.04)
<PER-SHARE-DIVIDEND>                            (0.28)
<PER-SHARE-DISTRIBUTIONS>                         0.00
<RETURNS-OF-CAPITAL>                              0.00
<PER-SHARE-NAV-END>                              16.68
<EXPENSE-RATIO>                                   0.32



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission